This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages without signing in

Acute prostatitis

Authoring team

Acute bacterial prostatitis is an acute focal or diffuse suppurative inflammation of the prostate gland.

Acute prostatitis is a bacterial infection needing prompt treatment with antibiotics.

Gram-negative bacteria are the most common causative pathogens in acute prostatitis, most commonly (1)

  • Escherichia coli,
  • Proteus species,
  • Klebsiella species and
  • Pseudomonas species

The prostate is usually involved as a consequence of:

  • direct extension from the posterior urethra or urinary bladder
  • distant spread in the blood or lymphatics

Occasionally, infection may spread from the rectum.

Complications of acute prostatitis include:

  • acute urinary retention secondary to prostatic oedema,
  • chronic prostatitis,
  • prostatic abscess,
  • bacteraemia,
  • epididymitis and
  • pyelonephritis

Notes:

  • in England, resistance of E. coli (the main causative organism of acute prostatitis) in laboratory processed urine specimens to the following antibiotics is:
    • ciprofloxacin: 10.6% (varies by area from 7.8% to 13.7%)
    • trimethoprim: 30.3% (varies by area from 27.1% to 33.4%) (Public Health England. Antimicrobial resistance quarterly surveillance: March 2018)

Reference:


Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.